Alpha Articles
Famvir Plus Zadaxin Beneficial In HBV
5 November 1998
MPS-I Treatment Set For Filing In 1999?
4 November 1998
Senetek & ICN Agreement For AdrenaJect (ReliaJect)
29 October 1998
Phase III Results Of Hectorol Announced
28 October 1998
Antisense '98 - The Key Players In R&D
22 October 1998
Pompe Disease JV For Genzyme Gen and Pharming
20 October 1998
Synthelabo Pipeline
15 October 1998
Remicade Now Available For Crohn's In First Market
15 October 1998
MMP Inhibition May Have Role In Meningitis
14 October 1998
New Drugs, Vaccine Shift Balance In War Against Flu
30 September 1998
Surge in Profits Expected For Yoshitomi
18 September 1998
Bayer's Acarbose Success In UKPDS
17 September 1998
P&U Gains Miglitol Rights
10 September 1998
Yoshitomi Gearing Up For Further Global Expansion
9 September 1998
Bayer's Prolastin Starts Phase II
8 September 1998
Solid Growth Forecast For Schering Plough
24 August 1998
Novartis Starts Phase III Iloperidone Trials
20 August 1998
Altana Expands Overseas Thanks To Pantoprazole
13 August 1998
Ilex Phase III Skin Cancer Trial
6 August 1998
Canadian Filing For One-Alpha D2
6 August 1998
AVAX' Melanoma Vaccine
30 July 1998
AAT Patent In Respiratory Distress
23 July 1998
Low-Dose Interferon Alpha For Fibromyalgia
14 July 1998
"Extraordinary"Viagra Sales Lift Pfizer Earnings
10 July 1998
PPL's Cystic Fibrosis Treatment Promising
9 July 1998
Miglitol Debuts In Germany
18 June 1998
Yoshitomi Views Benefits Of Green Cross Merger
15 June 1998
Viagra Still Riding High, But Competition Looms
15 June 1998
FDA Clears Rebetron, New Therapy For Hepatitis C
15 June 1998
FDA Panel Backs Centocor's Avakine For Crohn's
4 June 1998
FDA Panel Backs Centocor's Avakine For Crohn's
1 June 1998
S-P In Japan Begins Trial Of SciClone's Zadaxin
14 May 1998
Horrobin Severs Scotia Links After Restructuring
14 May 1998
Merck & Co's Propecia "Not Effective In Women"
14 May 1998
AAT Gene Therapy
13 May 1998
Horrobin Severs Scotia Links After Restructuring
12 May 1998
Abbott Loses Apotex Battle
30 April 1998
Betafectin Data Support Trial Continuation
30 April 1998
Sweden's Karo Bio Reports Progress
15 April 1998
Pfizer Posts Double-Digit Sales & Earnings Growth
15 April 1998
GW Licenses Patents From Synaptic For $2m
2 April 1998
Pacific Pharmaceuticals To Enter Clinic With BOPP
1 April 1998
New Gene Therapy Approach Effective
20 March 1998
Dimethaid's Immune Modulator WF10
19 March 1998
PPL's AAT Gets Orphan Status
18 March 1998
Bayer "Unperturbed" By Wave Of Mergers
18 March 1998
Zadaxin May Have Wound-Healing Effects
16 March 1998
Tokyo Stock Comment
12 March 1998
Celgene Begins SelCID Trial
12 March 1998
Appointment At Alpha Therapeutic
5 March 1998
Long-Term Efficacy With Merck & Co's Proscar
5 March 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
World Market For Biopharmaceuticals
27 February 1998
Biotech Promise For Rheumatoid Arthritis
26 February 1998
Clinical Trial News In Brief
17 February 1998
Hep C Drug Given Priority Status
22 January 1998
Synaptic & Grunenthal In Pain Alliance
21 January 1998
1997 Sales Reach $11.88 Billion At Abbott Labs
20 January 1998
Clinical Trial News In Brief
20 January 1998
Proleukin Approved For Melanoma In USA
15 January 1998
Propecia Approved In USA For Male Pattern Baldness
12 January 1998
CAT Ends 1997 In Healthy Position
17 December 1997
Roche's Zenapax Gets First Approval For Transplants
17 December 1997
S-P Files NDA For Rebetol Plus Intron-A
11 December 1997
Zeneca Allays Fears Of Near-Term Product Gap
4 December 1997
New Clinical Trials In Brief
4 December 1997
First Data For Roche's Nepicastat In CHF
25 November 1997
S-P Begins Ph II Zadaxin Trials
20 November 1997
Product License News In Brief
20 November 1997
FDA C'tee Raises Concerns Over Merck's Propecia
19 November 1997
Alpha Therapeutic On Track With Oncolym
6 November 1997
Zeneca Unveils AAT Diagnostic
6 November 1997
Confirmation Trial For Alpha-Beta's Betafectin
6 November 1997
Bone Care To File For One-Alpha D2
6 November 1997
AVAX Begins Ph III With Cancer Vaccine
30 October 1997
Roche's Zenapax Gets Backing Of FDA Panel
23 October 1997
Centocor's Avakine Effective In Crohn's
16 October 1997
Italchimici And Verigen In PASSTNF-alpha Deal
9 October 1997
GI's Benefix Approved By EMEA
9 October 1997
New Advances In The Treatment Of Sepsis?
9 October 1997
Euro Union CPMP September Meeting
8 October 1997
Glaxo Wellcome Buys Stake In Biddle Sawyer Of India
7 October 1997
Celgene Reports Progress With Immunology Program
2 October 1997
Korea's LG In Deal With Merck KGaA
1 October 1997
Research Collaboration For Allergan and ACADIA
29 September 1997
Alpha-Beta Cuts Workforce In Wake Of Betafectin Delays
23 September 1997
Duke University's Orphan Drug Designation Approved
11 September 1997
Vertex And Alpha End VX-366 Deal
11 September 1997
Isis Begins Ph I With ISIS 2503
11 September 1997
Development Of Biomedicine In China
3 September 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
Alpha-Beta's Betafectin, Disappointing Ph III Data
6 August 1997
Alpha-Beta's Betafectin, Ph III
5 August 1997
Teva's Strength: Coping With Change
21 July 1997
Novartis Unveils Strong Product Pipeline
1 July 1997
Alpha-Beta Acquires MycoTox
26 June 1997
Alpha Beta Shares Rise On Betafectin Hopes
12 June 1997
Deja Vu As Yet Another Sepsis Drug Fails
26 May 1997
Isis' Anti-PKC-alpha Promising In Phase I
26 May 1997
Investors Impressed With Glaxo Wellcome Pipeline
12 May 1997
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
